Introduced
by
To prohibit health insurance providers or plans from acting on a drug company’s behalf by paying or providing incentives to doctors to use or not use particular drugs, subject to a $25,000 fine. The bill also would impose annual reporting requirements.
Referred to the Committee on Health Policy
